Ceredase (Genzyme Corp) en es it fr

Ceredase (Genzyme Corp) Brand names, Ceredase (Genzyme Corp) Analogs

Ceredase (Genzyme Corp) Brand Names Mixture

  • No information avaliable

Ceredase (Genzyme Corp) Chemical_Formula

C2532H3854N672O711S16

Ceredase (Genzyme Corp) RX_link

http://www.rxlist.com/cgi/generic3/ceredase.htm

Ceredase (Genzyme Corp) fda sheet

Ceredase (Genzyme Corp) msds (material safety sheet)

Ceredase (Genzyme Corp) Synthesis Reference

No information avaliable

Ceredase (Genzyme Corp) Molecular Weight

55597.4

Ceredase (Genzyme Corp) Melting Point

No information avaliable

Ceredase (Genzyme Corp) H2O Solubility

No information avaliable

Ceredase (Genzyme Corp) State

Liquid

Ceredase (Genzyme Corp) LogP

-0.168

Ceredase (Genzyme Corp) Dosage Forms

Solution (IV Infusion)

Ceredase (Genzyme Corp) Indication

For the treatment of Gaucher's disease (deficiency in glucocerebrosidase)

Ceredase (Genzyme Corp) Pharmacology

Gaucher disease is characterized by a functional deficiency in Beta-glucocerebrosidase enzymatic activity and the resultant accumulation of lipid glucocerebroside in tissue macrophages which become engorged and are termed Gaucher cells. Gaucher cells are typically found in liver, spleen and bone marrow. This can lead to an enlarged spleen and liver (hepatosplenomegaly). Secondary hematologic sequelae include severe anemia and thrombocytopenia. Injections of alglucerase into Gaucher disease patients leads to elevated serum levels of the enzyme and reduction in the accumulation of glucocerebroside

Ceredase (Genzyme Corp) Absorption

No information avaliable

Ceredase (Genzyme Corp) side effects and Toxicity

No information avaliable

Ceredase (Genzyme Corp) Patient Information

No information avaliable

Ceredase (Genzyme Corp) Organisms Affected

Humans and other mammals